257 related articles for article (PubMed ID: 11981037)
1. DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha.
Delerive P; De Bosscher K; Vanden Berghe W; Fruchart JC; Haegeman G; Staels B
Mol Endocrinol; 2002 May; 16(5):1029-39. PubMed ID: 11981037
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1.
Delerive P; De Bosscher K; Besnard S; Vanden Berghe W; Peters JM; Gonzalez FJ; Fruchart JC; Tedgui A; Haegeman G; Staels B
J Biol Chem; 1999 Nov; 274(45):32048-54. PubMed ID: 10542237
[TBL] [Abstract][Full Text] [Related]
3. Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators.
Delerive P; Gervois P; Fruchart JC; Staels B
J Biol Chem; 2000 Nov; 275(47):36703-7. PubMed ID: 10980195
[TBL] [Abstract][Full Text] [Related]
4. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
Roussel RR; Barchowsky A
Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
[TBL] [Abstract][Full Text] [Related]
5. Identification by in vivo genomic footprinting of a transcriptional switch containing NF-kappaB and Sp1 that regulates the IkappaBalpha promoter.
Algarté M; Kwon H; Génin P; Hiscott J
Mol Cell Biol; 1999 Sep; 19(9):6140-53. PubMed ID: 10454561
[TBL] [Abstract][Full Text] [Related]
6. PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation.
Meissner M; Stein M; Urbich C; Reisinger K; Suske G; Staels B; Kaufmann R; Gille J
Circ Res; 2004 Feb; 94(3):324-32. PubMed ID: 14684628
[TBL] [Abstract][Full Text] [Related]
7. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
9. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.
Yu Z; Zhang W; Kone BC
Biochem J; 2002 Oct; 367(Pt 1):97-105. PubMed ID: 12057007
[TBL] [Abstract][Full Text] [Related]
10. Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.
Dreyfus DH; Nagasawa M; Gelfand EW; Ghoda LY
BMC Immunol; 2005 Jun; 6():12. PubMed ID: 15969767
[TBL] [Abstract][Full Text] [Related]
11. Homeostatic regulatory role of Pokemon in NF-κB signaling: stimulating both p65 and IκBα expression in human hepatocellular carcinoma cells.
Zhang NN; Sun QS; Chen Z; Liu F; Jiang YY
Mol Cell Biochem; 2013 Jan; 372(1-2):57-64. PubMed ID: 23054188
[TBL] [Abstract][Full Text] [Related]
12. Sp1-dependent regulation of PPARα in bone metabolism.
Duttenhoefer F; Biswas SK; Igwe JC; Sauerbier S; Bierhaus A
Int J Oral Maxillofac Implants; 2014; 29(1):e107-16. PubMed ID: 24451878
[TBL] [Abstract][Full Text] [Related]
13. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
Griffin BD; Moynagh PN
Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
[TBL] [Abstract][Full Text] [Related]
14. Ctenopharyngodon idella NF-κB subunit p65 modulates the transcription of IκBα in CIK cells.
Wang H; Zhu Y; Xu X; Wang X; Hou Q; Xu Q; Sun Z; Mi Y; Hu C
Fish Shellfish Immunol; 2016 Jul; 54():564-72. PubMed ID: 27142933
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB site interacts with Sp factors and up-regulates the NR1 promoter during neuronal differentiation.
Liu A; Hoffman PW; Lu W; Bai G
J Biol Chem; 2004 Apr; 279(17):17449-58. PubMed ID: 14970236
[TBL] [Abstract][Full Text] [Related]
16. Basal expression of IkappaBalpha is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator Notch1.
Oakley F; Mann J; Ruddell RG; Pickford J; Weinmaster G; Mann DA
J Biol Chem; 2003 Jul; 278(27):24359-70. PubMed ID: 12700242
[TBL] [Abstract][Full Text] [Related]
17. A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes.
Huang TT; Kudo N; Yoshida M; Miyamoto S
Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1014-9. PubMed ID: 10655476
[TBL] [Abstract][Full Text] [Related]
18. Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes.
Wang X; Sonenshein GE
J Virol; 2005 Jan; 79(1):95-105. PubMed ID: 15596805
[TBL] [Abstract][Full Text] [Related]
19. Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression.
Aguilera C; Hoya-Arias R; Haegeman G; Espinosa L; Bigas A
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16537-42. PubMed ID: 15536134
[TBL] [Abstract][Full Text] [Related]
20. Activation of nuclear orphan receptor NURR1 transcription by NF-kappa B and cyclic adenosine 5'-monophosphate response element-binding protein in rheumatoid arthritis synovial tissue.
McEvoy AN; Murphy EA; Ponnio T; Conneely OM; Bresnihan B; FitzGerald O; Murphy EP
J Immunol; 2002 Mar; 168(6):2979-87. PubMed ID: 11884470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
